product description:
Generic name: Metronidazole (flagyl, metro midazole, and metronidazole).
Chemical name: 2-methyl-5-nitroimidazole-1-ethanol.
Chemical formula: C6H9N3O3
Molecular weight: 171.15
CAS code: 443-48-1.
Properties: This product is white or light yellow crystal or crystalline powder; slightly smelly, bitter and slightly salty in taste. This product is slightly soluble in ethanol, slightly soluble in water or chloroform, and is very slightly soluble in ether.
Shelf life and storage: 48 months (shaded and sealed).
Available for preparation:
Products applications: (1) Metronidazole tablets (2) Metronidazole vaginal effervescent tablets (3) Metronidazole injection (4) Metronidazole Suppositories (5) Metronidazole capsules (6) Metronidazole glucose injection.
Packaging: 25KG/fiber can or packaging according to customer requirements.
Indications: It is used for the treatment of intestinal and parenteral amebiasis (such as amebic liver abscess and pleural amoebiasis). It can also be used for the treatment of vaginal trichomoniasis, balantidiosis, cutaneous leishmaniasis, guinea worm infection, etc. At present, it is also widely used for the treatment of anaerobic infections.
Metronidazole is a kind of nitroimidazole antibiotics, also known as metronidazole, metronidazole, metronidazole and metronidazole. It can kill anaerobes. The metabolites produced when it is reduced in human body also have anti anaerobes effect, inhibit the synthesis of deoxyribonucleic acid, interfere with the growth and reproduction of bacteria, and eventually lead to the death of bacteria, Anti anaerobes generally include: Bacteroides fragilis, Fusobacterium (named for its sharp spindle shape at both ends), tetanus, peptococcus, peptococcus and Giardia. It was initially used for the treatment of vaginal trichomoniasis, and the clinical effect is very significant. Later, it was found that metronidazole can also kill the anaerobic bacteria causing oral infection. In 1978, it was identified as a specific drug for anti anaerobic bacteria infection by the World Health Organization, which was widely used in the prevention and treatment of oral anaerobic bacteria infection. In hospital, this product is often used to prevent and treat respiratory tract, digestive tract, abdominal and pelvic infections caused by anaerobic bacteria, skin and soft tissue and bone and joint infections, pericarditis, sepsis and brain diseases.
IUPAC
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
Matter Classification
organic
Appearance
white to light yellow crystalline
Acidity and Basicity
alkalinity,
oxidizability,
reducibility
Risk Code
R40-46-45-39/23/24/25-23/24/25-11